This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Academia Sinica, Taipei Medical University. Active years: 2016.
Company Filing History:
1 out of 726 
1 out of 146 
Years Active: 2016
Title: Innovations of Shui-Tsung Chen in Endometriosis Detection
Introduction
Shui-Tsung Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of endometriosis. His work focuses on the development of specific monoclonal antibodies that can aid in diagnosing this condition.
Latest Patents
Shui-Tsung Chen holds a patent for "Specific A1AT monoclonal antibodies for detection of endometriosis." This patent describes monoclonal antibodies with a high binding affinity to isoforms of alpha 1-antitrypsin (A1AT). The invention includes hybridoma cells producing these antibodies and their applications in diagnosing and detecting endometriosis from serum samples of subjects suspected of having the condition or undergoing health examinations. He has 1 patent to his name.
Career Highlights
Throughout his career, Shui-Tsung Chen has worked with prestigious institutions such as Academia Sinica and Taipei Medical University. His research has significantly advanced the understanding and detection of endometriosis, contributing to better health outcomes for patients.
Collaborations
Shui-Tsung Chen has collaborated with esteemed colleagues, including Wei-Chung Yang and Hwei-Jiung Wang. Their joint efforts have furthered research in the field of medical diagnostics.
Conclusion
Shui-Tsung Chen's innovative work in developing monoclonal antibodies for endometriosis detection showcases his commitment to advancing medical science. His contributions are vital for improving diagnostic methods and patient care.